Medical Center - University Of Freiburg — Sponsor Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

6 Recruiting

4 Completed trials

6 Countries active

22 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I/II

Phase III: 4 Phase II: 4 Phase I/II: 2

Oversight events:

1 corrective measure across 1 trial

View oversight register →

100%

4 of 4 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Chronic graft versus host disease 2 Adverse drug reaction 1 BRAF gene mutation 1

Top IMPs

METHOXSALEN 2 ALLOGENEIC CD4+ AND CD8+ T LYMPHOCYTES EX VIVO INCUBATED WITH SYNTHETIC PEPTIDES OF THE VIRAL ANTIGENS OF CYTOMEGALOVIRUS, ADENOVIRUS AND EPSTEIN-BARR VIRUS 1 ATROPINE SULFATE 1 BELUMOSUDIL MESILATE 1 PEMBROLIZUMAB 1 PLACEBO 1 RUXOLITINIB 1 SORAFENIB 1 TRAMETINIB 1 TRETINOIN 1

All trials

10 total

BEAT-GVHD (Belumosudil for acute/chronic GVHD overlap syndrome) Recruiting

2025-521940-39-00 Phase II 1 country BELUMOSUDIL MESILATE
Phase 2 Trial to determine the safety and efficacy of simultaneous treatment with ruxolitinib and extracorporeal photopheresis for patients … Recruiting

2023-507754-33-00 Phase II 2 countries METHOXSALEN; RUXOLITINIB
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line tr… Recruiting

2024-512320-11-00 Phase III 2 countries
Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or … Recruiting

2023-507461-26-00 Phase III 1 country PLACEBO; TRETINOIN
Treatment of chemo-refractory viral infections after allogeneic stem cell transplantation with multispecific T cells against CMV, EBV and Ad… Recruiting

2024-512321-84-00 Phase III 5 countries ALLOGENEIC CD4+ AND CD8+ T LYMPHOCYTES EX VIVO INCUBATED WITH SYNTHETIC PEPTIDES…
Stereotactic Cisternal Lavage Therapy in Patients with Aneurysmal Subarachnoid Hemorrhage with Urokinase and Nimodipine for the Prevention o… Recruiting

2024-517798-25-00 Phase II 1 country
Radiotherapy in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to… Ended

2024-513633-20-00 Phase II 1 country PEMBROLIZUMAB
Low-dose AtropIne for Myopia control in children Ended

2024-513091-17-00 Phase III 1 country ATROPINE SULFATE
Treatment of advanced-stage malignancies harboring BRAF mutations with combination of Sorafenib and Trametinib: a multicenter study Ended

2024-512887-77-00 Phase I/II 1 country SORAFENIB; TRAMETINIB
Extracorporeal photopheresis as treatment for immune related adverse events after immunotherapy Ended

2024-513614-36-00 Phase I/II 1 country METHOXSALEN

Showing 1–10 of 10 trials

← All sponsors A–Z